nach oben

Erschienen in:

2016 | OriginalPaper | Buchkapitel

11. Demenzielle Erkrankungen bei Menschen mit Down-Syndrom

verfasst von : Dr. Antonia Coppus, Hildegard Telbis-Kankainen

Erschienen in: Lebensqualität im Alter

Verlag: Springer Fachmedien Wiesbaden

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Zusammenfassung

Die Lebenserwartung von Menschen mit DS hat in den letzten Jahrzehnten stark zugenommen. Ungefähr 80 % der Menschen mit DS werden beim Älterwerden eine Demenz entwickeln. Somit bildet diese Gruppe die Population mit dem höchsten genetischen Risiko für Demenz. Um diese Diagnose zu stellen, gehört eine korrekte Handhabung der Diagnostik mit einer multidisziplinären Annährung dazu. Andere mögliche Ursachen eines Rückgangs des Funktionsniveaus müssen ausgeschlossen werden. Eine medizinische Behandlung der Demenz ist jedoch nicht möglich. Die Behandlung besteht aus psychosozialen Interventionen, wobei Ko-Morbidität wie beispielsweise Epilepsie auch beachtet werden müssen. Nach der Diagnosestellung Demenz muss man für eine optimale Lebensqualität und eine gute palliative Begleitung sorgen.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Demenz im Arbeitsalltag der Mitarbeiter(innen) von stationären Behinderteneinrichtungen

Nächstes Kapitel Früherkennung von Demenzerkrankungen bei Menschen mit geistiger Behinderung mit psychometrischen Instrumenten

APA. (2000). American Psychiatric Association: Diagnostic and statistical manual of mental disorders (4. überarb. Aufl.) (DSM-IV-TR) APA. Neu Dehli: Jaypee Brothers Medical Publisher.

Aylward, E. H., Burt, D. B., Thorpe, L. U., Lai, F., & Dalton, A. (1997). Diagnosis of dementia in individuals with intellectual disability. Journal of Intellectual Disability Research, 41(2), 152–164.CrossRef

Bittles, A. H., Bower, C., Hussain, R., & Glasson, E. J. (2007). The four ages of Down syndrome. European Journal of Public Health, 17(2), 221–225.CrossRef

Burt, D. B., & Aylward, E. H. (2000). Test battery for the diagnosis of dementia in individuals with intellectual disability. Working Group for the Establishment of Criteria for the Diagnosis of Dementia in Individuals with Intellectual Disability. Journal of Intellectual Disability Research, 44(2), 175–180.CrossRef

Cohen, S. I., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. (2013). Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Proceedings of the National Academy of Sciences of the United States of America, 110(24), 9758–9763.CrossRef

Cooper, S. A., Melville, C. A., & Einfeld, S. L. (2003). Psychiatric diagnosis, intellectual disabilities and Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD). Journal of Intellectual Disability Research, 47(1), 3–15.CrossRef

Coppus, A. M. W. (2015). Dementia and Mortality in Down syndrome, results from a follow-up study.

Coppus, A., Evenhuis, H., Verberne, G. J., Visser, F., van Gool, P., Eikelenboom, P., & van Duijin, C. (2006). Dementia and mortality in persons with Down’s syndrome. Journal of Intellectual Disability Research, 50(10), 768–777.CrossRef

Coppus, A. M., Evenhuis, H. M., Verberne, G. J., Visser, F. E., Arias-Vasquez, A., Sayed-Tabatabaei, F. A., Vergeer-Drop, J., Eikelenboom, P., van Gool, W. A., & van Duijn, C. M. (2008a). The impact of apolipoprotein E on dementia in persons with Down’s syndrome. Neurobiology of Aging, 29(6), 828–835.CrossRef

Coppus, A. M., Evenhuis, H. M., Verberne, G. J., Visser, F. E., Oostra, B. A., Eikelenboom, P., van Gool, W. A., Janssens, A. C., & van Duijn, C. M. (2008b). Survival in elderly persons with Down syndrome. Journal of the American Geriatrics Society, 56(12), 2311–2316.CrossRef

Coppus, A. M., Fekkes, D., Verhoeven, W. M., Evenhuis, H. M., & van Duijn, C. M. (2009). Neopterin and the risk of dementia in persons with Down syndrome. Neuroscience Letters, 458(2), 60–64.CrossRef

Coppus, A. M., Schuur, M., Vergeer, J., Janssens, A. C., Oostra, B. A., Verbeek, M. M., & van Duijn, C. M. (2012). Plasma beta amyloid and the risk of Alzheimer’s disease in Down syndrome. Neurobiology of Aging, 33(9), 1988–1994.CrossRef

Dekker, A. D., Coppus, A. M., Vermeiren, Y., Aerts, T., van Duijn, C. M., Kremer, B. P., Naude, P. J., Van Dam, D., & De Deyn, P. P. (2014). Serum MHPG strongly predicts conversion to Alzheimer’s Disease in behaviorally characterized subjects with Down syndrome. Journal of Alzheimer’s Disease, 43, 871–891.

Evenhuis, H. M. (1992). Evaluation of a screening instrument for dementia in ageing mentally retarded persons. Journal of Intellectual Disability Research, 36(4), 337–347.CrossRef

Evenhuis, H. M. (1996). Further evaluation of the dementia questionnaire for persons with mental retardation (DMR). Journal of Intellectual Disability Research, 40(4), 369–373.CrossRef

Evenhuis, H. M., Theunissen, M., Denkers, I., Verschuure, H., & Kemme, H. (2001). Prevalence of visual and hearing impairment in a Dutch institutionalized population with intellectual disability. Journal of Intellectual Disability Research, 45(5), 457–464.CrossRef

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198.CrossRef

Glasson, E. J., Sullivan, S. G., Hussain, R., Petterson, B. A., Montgomery, P. D., & Bittles, A. H. (2002). The changing survival profile of people with Down’s syndrome: Implications for genetic counselling. Clinical Genetics, 62(5), 390–393.CrossRef

Hanney, M., Prasher, V., Williams, N., Jones, E. L., Aarsland, D., Corbett, A., Lawrence, D., Yu, L. M., Tyrer, S., Francis, P. T., Johnson, T., Bullock, R., Ballard, C., & researchers, M. t. (2012). Memantine for dementia in adults older than 40 years with Down’s syndrome (MEADOWS): A randomised, double-blind, placebo-controlled trial. Lancet, 379(9815), 528–536.CrossRef

Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science, 297(5580), 353–356.CrossRef

Hartley, S. L., Handen, B. L., Devenny, D. A., Hardison, R., Mihaila, I., Price, J. C., Cohen, A. D., Klunk, W. E., Mailick, M. R., Johnson, S. C., & Christian, B. T. (2014). Cognitive functioning in relation to brain amyloid-beta in healthy adults with Down syndrome. Brain, 137(9), 2556–2563.CrossRef

Holland, A. J., Hon, J., Huppert, F. A., Stevens, F., & Watson, P. (1998). Population-based study of the prevalence and presentation of dementia in adults with Down’s syndrome. British Journal of Psychiatry, 172, 493–498.CrossRef

Holland, A. J., Hon, J., Huppert, F. A., & Stevens, F. (2000). Incidence and course of dementia in people with Down’s syndrome: Findings from a population-based study. Journal of Intellectual Disability Research, 44(2), 138–146.CrossRef

Hon, J., Huppert, F. A., Holland, A. J., & Watson, P. (1999). Neuropsychological assessment of older adults with Down’s syndrome: An epidemiological study using the Cambridge Cognitive Examination (CAMCOG). British Journal of Clinical Psychology, 38(2), 155–165.CrossRef

Lott, I. T., Doran, E., Nguyen, V. Q., Tournay, A., Head, E., & Gillen, D. L. (2011). Down syndrome and dementia: A randomized, controlled trial of antioxidant supplementation. American Journal of Medical Genetics A, 155A(8), 1939–1948.CrossRef

Mann, D. M. A. (2006). Neuropathology of Alzheimer’s disease in Down syndrome. Abingdon: Radcliffe Publishing Ltd.

Margallo-Lana, M. L., Moore, P. B., Kay, D. W., Perry, R. H., Reid, B. E., Berney, T. P., & Tyrer, S. P. (2007). Fifteen-year follow-up of 92 hospitalized adults with Down’s syndrome: Incidence of cognitive decline, its relationship to age and neuropathology. Journal of Intellectual Disability Research, 51(6), 463–477.CrossRef

McCarron, M., Gill, M., McCallion, P., & Begley, C. (2005). Health co-morbidities in ageing persons with Down syndrome and Alzheimer’s dementia. Journal of Intellectual Disability Research, 49(7), 560–566.CrossRef

Mohan, M., Bennett, C., & Carpenter, P. K. (2009a). Galantamine for dementia in people with Down syndrome. Cochrane Database Syst Rev, (1), CD007656.

Mohan, M., Bennett, C., & Carpenter, P. K. (2009b). Rivastigmine for dementia in people with Down syndrome. Cochrane Database Syst Rev, (1), CD007658.

Mohan, M., Carpenter, P. K., & Bennett, C. (2009c). Donepezil for dementia in people with Down syndrome. Cochrane Database Syst Rev, (1), CD007178.

Mullins, D., Daly, E., Simmons, A., Beacher, F., Foy, C. M., Lovestone, S., Hallahan, B., Murphy, K. C., & Murphy, D. G. (2013). Dementia in Down’s syndrome: An MRI comparison with Alzheimer’s disease in the general population. Journal of Neurodevelopmental Disorders, 5(1), 19.CrossRef

Oliver, C., Crayton, L., Holland, A., Hall, S., & Bradbury, J. (1998). A four year prospective study of age-related cognitive change in adults with Down’s syndrome. Psychological Medicine, 28(6), 1365–1377.CrossRef

Prasher, V. P. (1999). Down syndrome and thyroid disorders: A review. Down Syndrome Research and Practice, 6(1), 25–42.CrossRef

Prasher, V., & Haque, M. S. (2005). Misdiagnosis of thyroid disorders in down syndrome: Time to re-examine the myth? American Journal of Mental Retardation, 110(1), 23–27.CrossRef

Prasher, V. P., Farrer, M. J., Kessling, A. M., Fisher, E. M., West, R. J., Barber, P. C., & Butler, A. C. (1998). Molecular mapping of Alzheimer-type dementia in Down’s syndrome. Annals of Neurology, 43(3), 380–383.CrossRef

Prasher, V., Cumella, S., Natarajan, K., Rolfe, E., Shah, S., & Haque, M. S. (2003). Magnetic resonance imaging, Down’s syndrome and Alzheimer’s disease: Research and clinical implications. Journal of Intellectual Disability Research, 47(2), 90–100.CrossRef

Prasher, V. P., Sajith, S. G., Mehta, P., Zigman, W. B., & Schupf, N. (2010). Plasma beta-amyloid and duration of Alzheimer’s disease in adults with Down syndrome. International Journal of Geriatric Psychiatry, 25(2), 202–207.CrossRef

Roizen, N. J., & Patterson, D. (2003). Down’s syndrome. Lancet, 361(9365), 1281–1289.CrossRef

Schupf, N., & Sergievsky, G. H. (2002). Genetic and host factors for dementia in Down’s syndrome. British Journal of Psychiatry, 180, 405–410.CrossRef

Schupf, N., Kapell, D., Lee, J. H., Zigman, W., Canto, B., Tycko, B., & Mayeux, R. (1996). Onset of dementia is associated with apolipoprotein E epsilon4 in Down’s syndrome. Annals of Neurology, 40(5), 799–801.CrossRef

Schupf, N., Patel, B., Pang, D., Zigman, W. B., Silverman, W., Mehta, P. D., & Mayeux, R. (2007). Elevated plasma beta-amyloid peptide Abeta (42) levels, incident dementia, and mortality in Down syndrome. Archives of Neurology, 64(7), 1007–1013.CrossRef

Sekijima, Y., Ikeda, S., Tokuda, T., Satoh, S., Hidaka, H., Hidaka, E., Ishikawa, M., & Yanagisawa, N. (1998). Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down’s syndrome. European Neurology, 39(4), 234–237.CrossRef

Simard, M., & van Reekum, R. (2001). Dementia with Lewy bodies in Down’s syndrome. International Journal of Geriatric Psychiatry, 16(3), 311–320.CrossRef

Smiley, E., Cooper, S. A., Finlayson, J., Jackson, A., Allan, L., Mantry, D., McGrother, C., McConnachie, A., & Morrison, J. (2007). Incidence and predictors of mental ill-health in adults with intellectual disabilities: Prospective study. British Journal of Psychiatry, 191, 313–319.CrossRef

Sparrow, SS, Balla, D., & Cicchetti, D. V. (1984). Vineland adaptive behaviour scales, interview edition, expanded form manual. American Guidance Service. Minnesota: Circle Pines.

Strydom, A., & Hassiotis, A. (2003). Diagnostic instruments for dementia in older people with intellectual disability in clinical practice. Aging & Mental Health, 7(6), 431–437.CrossRef

Strydom, A., Livingston, G., King, M., & Hassiotis, A. (2007). Prevalence of dementia in intellectual disability using different diagnostic criteria. British Journal of Psychiatry, 191, 150–157.CrossRef

Thune-Boyle, I. C., Iliffe, S., Cerga-Pashoja, A., Lowery, D., & Warner, J. (2012). The effect of exercise on behavioral and psychological symptoms of dementia: Towards a research agenda. International Psychogeriatrics, 24(7), 1046–1057.CrossRef

Tyrrell, J., Cosgrave, M., McCarron, M., McPherson, J., Calvert, J., Kelly, A., McLaughlin, M., Gill, M., & Lawlor, B. A. (2001). Dementia in people with Down’s syndrome. International Journal of Geriatric Psychiatry, 16(12), 1168–1174.CrossRef

Van Buggenhout, G. J., Trommelen, J. C., Schoenmaker, A., De Bal, C., Verbeek, J. J., Smeets, D. F., Ropers, H. H., Devriendt, K., Hamel, B. C., & Fryns, J. P. (1999). Down syndrome in a population of elderly mentally retarded patients: Genetic-diagnostic survey and implications for medical care. American Journal of Medical Genetics, 85(4), 376–384.CrossRef

van Splunder, J., Stilma, J. S., Bernsen, R. M., Arentz, T. G., & Evenhuis, H. M. (2003). Refractive errors and visual impairment in 900 adults with intellectual disabilities in the Netherlands. Acta Ophthalmologica Scandinavica, 81(2), 123–129.CrossRef

Visser, F. E., Aldenkamp, A. P., van Huffelen, A. C., Kuilman, M., Overweg, J., & van Wijk, J. (1997). Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. American Journal of Mental Retardation, 101(4), 400–412.

Weijerman, M. E., van Furth, A. M., Vonk Noordegraaf, A., van Wouwe, J. P., Broers, C. J., & Gemke, R. J. (2008). Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: A national study. Journal of Pediatrics, 152(1), 15–19.CrossRef

WHO. (1993). World Health Organization, ICD-10: International Statistical Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO.

Wisniewski, K. E., Dalton, A. J., McLachlan, C., Wen, G. Y., & Wisniewski, H. M. (1985). Alzheimer’s disease in Down’s syndrome: Clinicopathologic studies. Neurology, 35(7), 957–961.CrossRef

Yang, Q., Rasmussen, S. A., & Friedman, J. M. (2002). Mortality associated with Down’s syndrome in the USA from 1983 to 1997: A population-based study. Lancet, 359(9311), 1019–1025.CrossRef

Titel: Demenzielle Erkrankungen bei Menschen mit Down-Syndrom
verfasst von: Dr. Antonia Coppus
Hildegard Telbis-Kankainen
Verlag: Springer Fachmedien Wiesbaden
Buch: Lebensqualität im Alter
Print ISBN: 978-3-658-09975-6

Electronic ISBN: 978-3-658-09976-3

Copyright-Jahr: 2016
DOI: https://doi.org/10.1007/978-3-658-09976-3_11